The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ursogrix 250 mg hard capsules

AS GrindeksPA22992/002/001

Main Information

Trade NameUrsogrix 250 mg hard capsules
Active SubstancesUrsodeoxycholic acid
Dosage FormCapsule, hard
Licence HolderAS Grindeks
Licence NumberPA22992/002/001

Group Information

ATC CodeA05AA02 ursodeoxycholic acid


License statusAuthorised
Licence Issued26/02/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back